Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2009

View Archived Issues

AlphaRx and Venturepharm sign agreement for drug development center in China

Laboratory Corporation acquires Monogram Biosciences pursuant to cash tender offer

New inhibitors of the MDM2-p53 interaction reported by Roche as oncolytics

Anesiva and Arcion Therapeutics sign definitive merger agreement

FDA requests stronger cancer warnings in prescribing information for TNF blockers

Radius reports results from phase II clinical trial of BA-058 in osteoporosis

Rib-X reports results from phase II clinical trial of radezolid in CAP

European Commission approves Novartis' Afinitor for RCC patients

Acura submits briefing package to FDA for Acurox NDA in moderate to severe pain

MJFF grants funding to Ceregene for long-term testing in phase II trial of CERE-120

ARRY-520 shows similar preclinical activity to paclitaxel without NF-kappaB and cytokine activation

Phase I/II data support clinical activity of icotinib in later stage non-small cell lung cancer

Neurological recovery induced by fenofibrate/simvastatin in rat model of traumatic brain injury

Rosiglitazone prevents stroke-induced inflammation in mouse model of type 2 diabetes

Early phase I/II data suggest safety and immunogenicity of HIV DNA vaccine in healthy subjects

Soluble epoxide hydrolase inhibitors described by Arete Therapeutics for vascular conditions

French researchers claim novel anticancer compounds

Amgen presents PI3Kalpha inhibitors for cancer treatment

Dipeptidyl peptidase IV inhibitors in early development at LG Life Sciences

Genelabs and Novartis disclose novel compounds for treating hepatitis C viral infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...